| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | CA2590639A1 Fluorochemical diesters as repellent polymer melt additives |
| 06/22/2006 | CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 06/21/2006 | EP1670807A1 Fluorescent labeled sphingosines |
| 06/21/2006 | EP1670752A1 2-cyanobenzenesulfonamides for combating animal pests |
| 06/21/2006 | EP1670749A1 2-substituted benzoic acid derivatives as hm74a receptor agonists |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1250321B1 Glyburide composition |
| 06/21/2006 | EP1146037B1 Process for the preparation of optically active amino alcohols |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/21/2006 | CN1791407A [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
| 06/20/2006 | US7064214 Reacting an amino-containing sulfinic acid with a metal hydrocarbon or halometal hydrocarbon to obtain a sterically pure product; pantoprazole; omeproazole; lansproazole; rabeproazoe; gastrointestinal disorders |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061549A1 Process for the preparation of tamsulosin and intermediates thereof |
| 06/15/2006 | WO2005089815A3 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128786 Compounds for the treatment of alzheimer's disease |
| 06/15/2006 | US20060128767 Methods of preparing sulfinamides and sulfoxides |
| 06/15/2006 | US20060128670 Pesticidally active ketone and oxime derivatives |
| 06/15/2006 | US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1668026A1 Detection of cholesterol ozonation products |
| 06/14/2006 | EP1667962A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667724A2 Albumin-binding derivatives of therapeutic peptides |
| 06/14/2006 | EP1496884B1 Association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006059700A1 Polysulfonamide derivative and use thereof |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/07/2006 | EP1664002A1 Organic compounds |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663113A2 Substituted sulfonamides |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1781904A Salts of demethyl phencynonate isomer and N-para-methyl-phenyl-sulfuryl glutamic acid optical isomer and their preparing method and use |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | USH2158 Process for the production of clavulanic acid salts |
| 06/06/2006 | US7057043 Processes for preparing aminophenylsulfonylureas, and intermediates therefor |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/01/2006 | WO2006056433A2 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 06/01/2006 | WO2006017214A3 Inhibitors of histone deacetylase |
| 06/01/2006 | US20060116361 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 06/01/2006 | CA2586520A1 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests |
| 05/31/2006 | EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 05/31/2006 | EP1660459A2 Arylsulfonamidobenzylic compounds |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660439A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 05/31/2006 | EP1660431A2 Phenoxyacetic acid derivatives |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | CN1780811A Diphenylethylene compounds and uses thereof |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053234 Antibacterial agents |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/30/2006 | CA2065128C Process for the preparation of phosphorus-containing l-amino acids, their derivatives and intermediates for this process |
| 05/26/2006 | WO2006055625A2 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 05/26/2006 | WO2006054115A1 Sulphonylated diphenylethylenediamines, method for their preparation and use in transfer hydrogenation catalysis |
| 05/26/2006 | CA2587726A1 Sulphonylated diphenylethylenediamines, method for their preparation and use in transfer hydrogenation catalysis |
| 05/26/2006 | CA2587566A1 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors |
| 05/25/2006 | US20060111585 Title of the invention n-cyclohexylaminocarbonyl benzensulfonmide derivatives |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111344 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 05/25/2006 | US20060110743 Drug evolution: drug design at hot spots |
| 05/25/2006 | US20060110343 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/24/2006 | EP1658265A1 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | CN1777812A Modulators of the G protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/23/2006 | US7049468 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1: |
| 05/23/2006 | US7049460 Aromatic guanidine compound; antitumor agents; anticancer agents |
| 05/18/2006 | WO2006051378A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds |
| 05/18/2006 | WO2006051373A1 Compounds for the treatment of diseases |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106089 Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
| 05/18/2006 | US20060106082 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation |
| 05/18/2006 | US20060106053 Therapy of adenocarcinoma of the colon and rectum |
| 05/18/2006 | CA2586135A1 Compositions and processes for preparing 13-deoxy-anthracyclines |
| 05/17/2006 | EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 05/17/2006 | EP1656132A2 Novel pyrrole-based hmg-coa reductase inhibitors |
| 05/17/2006 | EP1656095A2 N,n-dihalogenated amino acids and derivatives |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/16/2006 | US7045658 prophylaxis and treatment of respiratory diseases; phenethanolamine derivatives |
| 05/16/2006 | US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |